Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.ZEBOV and MVA-BN-Filo in Healthy Pregnant Women
NCT04556526Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2020
- Primary completion
- Mar 2023
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of zabdeno, Mvabea in Ebola virus disease (EVD), sponsored by Janssen Pharmaceutical. Started Oct 2020; status: completed.
02
Drugs
zabdenoMvabea
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT04556526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556526.